Comments
GSK in weekend talks to buy Human Genome: sources
16.07.2012. | LONDON/NEW YORK (Reuters) - GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech company for three months, sources familiar with the situation said on Sunday....
